Sunshine Biopharma Inc. Advertising Expense
Sunshine Biopharma Inc. (SBFM) reported Advertising Expense of $217.67 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2022-11-07
- Sunshine Biopharma Inc. advertising expense for the quarter ending 2022-09-30 was $217.67K.
- Sunshine Biopharma Inc. advertising expense for the quarter ending 2022-06-30 was $87.68K.
- Sunshine Biopharma Inc. advertising expense for the quarter ending 2022-03-31 was $95.04K.
- Sunshine Biopharma Inc. advertising expense for the quarter ending 2021-09-30 was $0.00.
| Period end | Advertising Expense 3 month | Advertising Expense 6 month | Advertising Expense 9 month |
|---|---|---|---|
| 2022-09-30 | $217.67K 10-Q · filed 2022-11-07 | $305.35K derived: sum of 2 quarters · filed 2022-11-07 | $400.39K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $87.68K 10-Q · filed 2022-08-03 | $182.72K 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $95.04K 10-Q · filed 2022-05-06 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-03 | $0.00 10-Q · filed 2022-08-03 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |